Ilian Iliev Ph.D Overview

  • Primary Position
  • Chief Executive...

  • Primary Industry
  • Information Technology

  • Active Board Seats
  • 8

  • Med. Deal Size

  • Med. Valuation

Ilian Iliev Ph.D General Information

Biography

Dr. Ilian Iliev serves as a Board Member at PDS Biotechnology. He served as Managing Director at EMV Capital. He also serves as Executive Director at Martlet Capital. He serves as a Board Member at Proaxsis. He serves as a Board Member at Wanda. He serves as Chairman at Wanda Health. He serves as Chief Executive Officer at NetScientific. He serves as a Board Member at Glycotest, Sofant Technologies, and Q-Bot. EMV Capital (EMVC), a corporate finance and VC investment firm acquired by NetScientific in August 2020. He co-owned Boliven. EMVC is a London-based investor in the industrial sustainability, industrials, and healthcare sectors. EMVC's investments in Europe, Israel, and the US cover a range of technologies including robotics and AI, machine learning, materials science, IoT, advanced engineering, power electronics, and medical devices. He spun out EMV Capital out of EcoMachines Ventures, which he co-founded in 2013. Prior to that, he co-founded and was CEO of Cambridge Ltd (2006-2012), which he built into a leading market and technology business intelligence provider in the UK. He is a board member at a number of Net Scientific and EMVC portfolio companies, including PDS Biotechnology Inc., Pointgrab, and Q-Bot, and he also serves as chairman at Vortex Biosciences. He holds a Ph.D. from Cambridge University's Judge Business School, focused on Venture Capital business models in emerging economies, a Mcom in Economics, and a BA in Politics, Economics, and International Relations from the University of Witwatersrand, South Africa. He has published widely on entrepreneurship, venture capital, and market trends in energy and healthcare, and has won awards for academic excellence.

Contact Information

Primary Position
Chief Executive Officer, EMV Capital
Education
University of the Witwatersrand, M.Comm (Master of Commerce)
Cambridge University, Ph.D. (Doctor of Philosophy)
University of the Witwatersrand, BA (Bachelor of Arts)
Gender
Male
Email
ii
Phone
+44 07786
Address
  • 20 Saint Andrew Street
  • London EC4A 3AG
  • England, United Kingdom
+44 020

Ilian Iliev Ph.D Positions (2)

Firm name Firm type Title Location Industry Since
EMV Capital Investor Chief Executive Officer London, United Kingdom Venture Capital
Martlet Capital Investor Executive Director Cambridge, United Kingdom Venture Capital

Ilian Iliev Ph.D Board Seats (8)

Company Industry Ownership Status Financing Status Location Since
Glycotest Biotechnology Privately Held (backing) Venture Capital-Backed Merion, PA
PDS Biotechnology Biotechnology Publicly Held Formerly VC-backed Princeton, NJ
PointGrab Business/Productivity Software Privately Held (backing) Venture Capital-Backed Kfar Saba, Israel
ProAxsis Diagnostic Equipment Privately Held (backing) Venture Capital-Backed Belfast, United Kingdom
Q-Bot Other Hardware Privately Held (backing) Venture Capital-Backed London, United Kingdom

Ilian Iliev Ph.D Lead Partner on Deals (27)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Sofant 05-Jun-2024 Later Stage VC Completed Wireless Communications Equipment Edinburgh, United Kingdom
DeepTech Recycling 31-May-2024 Completed Environmental Services (B2B) London, United Kingdom
Martlet Capital 13-May-2024 Completed Other Financial Services Cambridge, United Kingdom
Glycotest 23-Jan-2024 Completed Biotechnology Merion, PA
ProAxsis 01-Jan-2024 Completed Diagnostic Equipment Belfast, United Kingdom
Q-Bot 13-Sep-2023 Completed Other Hardware London, United Kingdom
DName-iT 30-Jun-2023 Completed Laboratory Services (Healthcare) Belfast, United Kingdom
Vortex Biotech 22-Jun-2023 Completed Environmental Services (B2B) Dubai, United Arab Emirates
Sofant 29-Nov-2022 Later Stage VC (Series A) Completed Wireless Communications Equipment Edinburgh, United Kingdom
Sofant 29-Nov-2022 Later Stage VC (Series A) Completed Wireless Communications Equipment Edinburgh, United Kingdom

Ilian Iliev Ph.D Network (163)

Board Members (66)

Name Company Representing Location From
Tomasz Lipinski Q-Bot Q-Bot London, United Kingdom
Yuejian Zhang Glycotest Fosun Pharma Merion, PA
Vortex Biosciences Vortex Biosciences Pleasanton, CA
Glycotest Self Merion, PA
PDS Biotechnology Edge Therapeutics Princeton, NJ

Portfolio Executives (97)

Name Company Role Deal date Location
Tughrul Arslan Ph.D Sofant Co-Founder, Board Member & Chief Scientist 05-Jun-2024 Edinburgh, United Kingdom
Victor Steel Sofant Chief Technology Officer, Technology Lead & Chief Marketing Officer 05-Jun-2024 Edinburgh, United Kingdom
Sofant Co-Founder, Board Member, Chief Scientific Officer & Vice President, Engineering 05-Jun-2024 Edinburgh, United Kingdom
Sofant Co-Founder, Board Member & Chief Operating Officer 05-Jun-2024 Edinburgh, United Kingdom
Sofant Chief Executive Officer & Board Member 05-Jun-2024 Edinburgh, United Kingdom

Ilian Iliev Ph.D Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
EMVC Evergreen EIS Fund EMV Capital (Acquired) Venture Capital - Early Stage Evergreen
EMV Capital Thematic Fund EMV Capital (Acquired) Venture Capital - Early Stage Upcoming

Ilian Iliev Ph.D FAQs

  • Who is Ilian Iliev Ph.D?

    Dr. Ilian Iliev serves as a Board Member at PDS Biotechnology.

  • How much does Ilian Iliev Ph.D typically invest?

    Ilian Iliev Ph.D's median deal size is .

  • What is Ilian Iliev Ph.D’s main position?

    Ilian Iliev Ph.D’s primary position is Chief Executive Officer.

  • What are the contact details for Ilian Iliev Ph.D?

    Ilian Iliev Ph.D’s email address is ii and his phone number is +44 07786 .

  • How many active board seats does Ilian Iliev Ph.D hold?

    Ilian Iliev Ph.D holds 8 board seats including Glycotest, PDS Biotechnology, PointGrab, ProAxsis, and Q-Bot.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »